🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, asserting the companies hid potential risks that the pain reliever created to pediatric neurological development.

The court filing follows a month after President Donald Trump promoted an unproven link between taking Tylenol - referred to as acetaminophen - while pregnant and autism spectrum disorder in offspring.

The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the sole analgesic recommended for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of discomfort and pushing pills regardless of the risks."

The company asserts there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These companies deceived for years, knowingly endangering numerous people to boost earnings," the attorney general, a Republican, stated.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its website, the company also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a proven link between consuming paracetamol and autism."

Groups acting on behalf of doctors and health professionals share this view.

ACOG has stated paracetamol - the key substance in Tylenol - is one of the few options for women during pregnancy to address discomfort and elevated temperature, which can present serious health risks if ignored.

"In more than two decades of studies on the use of paracetamol in pregnancy, not a single reputable study has conclusively proven that the usage of paracetamol in any trimester of gestation results in neurodevelopmental disorders in young ones," the organization commented.

The court filing references current declarations from the Trump administration in asserting the medication is allegedly unsafe.

In recent weeks, Trump raised alarms from public health officials when he told women during pregnancy to "struggle intensely" not to use Tylenol when ill.

The FDA then issued a notice that physicians should think about restricting the consumption of Tylenol, while also mentioning that "a causal relationship" between the drug and autism in young ones has not been established.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had vowed in spring to conduct "a massive testing and research effort" that would identify the source of autism in a matter of months.

But specialists cautioned that identifying a unique factor of autism - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and condition that influences how persons experience and interact with the surroundings, and is diagnosed using doctors' observations.

In his legal document, the attorney general - who supports Trump who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around acetaminophen and autism.

This legal action aims to force the companies "remove any promotional materials" that claims acetaminophen is reliable for pregnant women.

The court case parallels the grievances of a assembly of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in 2022.

Judicial authorities rejected the legal action, stating research from the parents' expert witnesses was inconclusive.